Fluorescence on-sensor for detecting BRCA2 and preparation method and application thereof
By designing a fluorescence-on sensor with molecular hairpin structure, the BRCA2 gene detection process is simplified, and the efficient identification of single-base mutations is achieved, and the complexity and cost problems in the existing technology are solved, providing a simple and specific A highly sensitive detection method.
Patent Information
- Application Number
- CN202211504554.6
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2022-11-28
- Publication Date
- 2024-11-26
- Estimated Expiration
- 2042-11-28
AI Technical Summary
When detecting BRCA2 gene mutations, the electrochemical method design is complex and costly. The fluorescent sensor has weak ability to recognize single-base mutations, and the preparation process is cumbersome or requires long-term preparation, which limits the popularization and application of sensors.
Design a fluorescence-on-activated sensor, which is dissolved in SPSC buffer by activation of molecular hairpin structure, and the detection of BRCA2 is achieved through specific sequences and TAMRA fluorophores, which simplifies the preparation and detection process, and is specific and can identify single Base mutation.
It realizes efficient and specific detection of BRCA2, simplifies the preparation and operation process, the detection limit is 1 nmol·L-1, and the correlation coefficient is greater than 0.99. It is suitable for early screening and genetic testing of breast cancer, and expands the application of gene sensors. .
Smart Images

Figure CN116004772B_ABST
Abstract
Description
Technical Field
[0001] The present invention belongs to the technical field of gene sensor preparation, and relates to a fluorescence on-sensor, and in particular to a fluorescence on-sensor for detecting BRCA2, and a preparation method and application thereof. Background Art
[0002] Breast cancer is a serious cancer that threatens women's life and health. Its incidence and mortality rates are increasing year by year worldwide. Breast cancer susceptibility gene 2 (BRCA2) is a susceptibility gene locus associated with hereditary breast-ovarian cancer syndrome discovered in 1995. It is involved in regulating cell cycle, repairing DNA damage, gene transcription and cell apoptosis, and is an important part of maintaining genome stability. If it undergoes gene mutation or deletion, it will affect chromosome stability and cause malignant transformation. Relevant data show that 50%-80% of hereditary breast cancer and ovarian cancer are caused by BRCA2 mutations. Therefore, screening for BRCA2 gene mutations has important clinical significance for risk assessment, disease detection, early diagnosis and gene therapy of breast cancer patients.
[0003] Domestic and foreign scholars have conducted long-term research on the detection methods of breast cancer genes and their mutations. In recent years, electrochemical sensor analysis has become a common method for BRCA gene detection due to its high sensitivity and low detection limit. Ribovski et al. used single-stranded thiol-modified DNA sequence (HS-ssDNA) as a probe fixed in a gold electrode, and used [Fe(CN)6] 4- The detection limit of the DNA sensor was 0.15 nmol·L -1 The linear range is 1-200 nmol·L -1 , and can distinguish up to double base mutations [Ribovski L, Zucolotto V, Janegitz B C. Microchemical Journal, 2017, 133: 37.]. Ehzari et al. used uniform polyether electrospinning to construct nanofibers with nanotubes (RCNFs-MWCNTs), fixed the DNA probe of the BRCA1 gene on NFs-MWCNTs, and used the impedance method to measure the BRCA1 sequence with a detection limit of 2.4 pmol·L -1, can specifically distinguish double base mutations [Ehzari H, Safari M, Shahlaei M. Microchemical Journal, 2018, 143: 118.]. The above electrochemical methods have high sensitivity, but their design methods are complex, the preparation process is cumbersome or special materials need to be modified on the electrode surface, resulting in high sensor preparation costs, and the sensor has weak recognition ability for single base mutations.
[0004] In addition, Liu et al. first established a label-free fluorescence method for detecting BRCA1 gene based on hairpin DNA template copper nanoclusters, which reduced the detection cost and achieved 2-600 nmol·L -1 Wide range detection with a detection limit of 2 nmol·L -1 , but the fluorescence intensity of its single base mismatch is almost the same as that of the target gene [Liu J, Wang T, Xiao B, et al. AnalyticalMethods, 2021, 13(5): 712.]. Zhong et al. designed a novel dual-channel biosensor donor-acceptor pair with CDs and AuNPs as the core, and labeled the fluorescent group cy3 at the 5' end of the hairpin structure and the fluorescence quencher BHQ2 at the 3' end to assist in the detection of dual genes, with a detection limit of 1.5 nmol·L for BRCA1. -1 [Zhong D, Yang K, Wang Y, et al. Talanta, 2017, 175: 217.] Dong et al. prepared a chiral miniPEG-γPNA array through 12 hours of preliminary preparation, which achieved large-scale sensitive detection of single-base mutations in BRCA1 gene-related oligonucleotide sequences (3099delT) with a detection limit of 5.97 nmol·L -1 [Borghei YS, Hosseini M, Ganjali MR, et al. Materials Science and Engineering: C, 2019, 97: 406.]. The above fluorescent sensors do not require electrode modification and have a relatively simple preparation process, but their specificity for single-base mutations is not obvious or the initial preparation time is long, which is not conducive to the further promotion and application of the sensors.
[0005] In summary, developing a sensor that is simple to prepare and operate and can effectively identify single-base mutations for BRCA testing is of great value for the promotion and application of gene sensors and the further preparation of biological reagents for predicting and evaluating breast cancer. Summary of the invention
[0006] In order to solve the above technical problems, the present invention proposes a fluorescence on-sensor for detecting BRCA2 and a preparation method and application thereof. Through a specially designed molecular hairpin structure, the detection of the target gene BRCA2 is achieved in one step without the need to modify the quenching group or use other special materials. The sensor preparation and detection process are extremely simple and have outstanding specificity. It can effectively identify single-base mutations, providing a new method for early prediction and evaluation of breast cancer.
[0007] In order to achieve the above object, the technical solution of the present invention is achieved as follows:
[0008] The preparation method of the fluorescence on sensor for detecting BRCA2 comprises the following steps: the molecular hairpin H1 is centrifuged and then dissolved in SPSC buffer for activation, and then allowed to stand in the dark for 2 hours to obtain a working solution of the fluorescence on sensor.
[0009] Preferably, the molecular hairpin H1 is a stem-loop structure, wherein the loop portion is composed of 5 guanine bases, and the stem portion includes a BRCA2 complementary sequence and a sequence that is partially complementary to the BRCA2 complementary sequence.
[0010] Preferably, the sequence of the molecular hairpin H1 is shown as SEQ ID No. 1, and a TAMRA group is modified between the last base and the first guanine base of the 5' end sequence.
[0011] Preferably, the formula of the SPSC buffer is NaH2PO450 mmol·L -1 and NaCl 1 mol·L -1 , adjust pH=8.0.
[0012] Preferably, the concentration of the molecular hairpin H1 is 150-600 nmol·L -1 .
[0013] The present invention also includes a fluorescence on sensor prepared by the above method.
[0014] The present invention also includes the use of the above-mentioned fluorescence on-sensor in preparing a biological detection tool for detecting BRCA2.
[0015] Further, the steps of detecting BRCA2 by the fluorescence on sensor are as follows: adding the SPSC buffer of the test solution to the working solution of the fluorescence on sensor, and then detecting the change value of the fluorescence intensity by using a fluorescence spectrophotometer, and substituting the fluorescence intensity change value into ΔF And its corresponding BRCA2 standard solution concentration c The concentration of BRCA2 in the test solution was calculated using the standard curve equation.
[0016] Preferably, the working conditions of the fluorescence on sensor are temperature 25°C, time 50 min, and pH = 8.0.
[0017] Preferably, the concentration of the molecular hairpin H1 in the working solution of the fluorescence on-sensor is 150 nmol·L -1 The detection range is 1-100 nmol·L -1 The standard curve equation is ΔF =10.362 c +83.629; the concentration of molecular hairpin H1 is 300 nmol·L -1 The detection range is 1-150 nmol·L -1 The standard curve equation is ΔF =10.511 c +104.194; the concentration of molecular hairpin H1 is 600 nmol·L -1 The detection range is 1-300 nmol·L -1 The standard curve equation is ΔF =12.408 c +162.828.
[0018] Beneficial effects of the present invention:
[0019] 1. In order to simplify the preparation process of gene sensors and improve their application possibilities, the present invention realizes the detection of the target gene BRCA2 in one step through the design of DNA molecular hairpin structure. The preparation and detection process of the fluorescence on sensor is extremely simple and has outstanding specificity. The stem of the molecular hairpin H1 contains a BRCA2 complementary sequence, and the junction between the stem and the loop is labeled with a tetramethylrhodamine (TAMRA) fluorescent group. The 5 G bases (guanine bases) in the loop quench part of the fluorescence signal through photoinduced electron transfer to reduce the background fluorescence signal; the BRCA2 sequence to be tested competes with the stem sequence of the molecular hairpin H1, the hairpin structure is opened, the fluorescence signal rises, and the one-step quantitative detection of the target gene can be achieved by measuring the intensity of the rising fluorescence signal.
[0020] 2. The present invention also optimizes the detection conditions of the fluorescence on-sensor and proves that under the optimal detection conditions (the reaction time of the target gene BRCA2 and the molecular hairpin H1 is 50 minutes, the reaction temperature is 25°C, and the pH is 8), the detection range of the fluorescence on-sensor is different when the concentration of the molecular hairpin H1 is different. By changing the concentration of H1, the linear detection range of the fluorescence on-sensor for BRCA2 can be 1-200 nmol·L -1 When the concentration of the molecular hairpin H1 is 150 nmol·L -1 、300 nmol·L -1 and 600 nmol·L-1 When the linear detection range of the fluorescent on-sensor of the present invention for BRCA2 is 1-50 nmol·L -1 , 1-100 nmol·L -1 and 1-200 nmol·L -1 The detection limits of the fluorescence on-sensors for the three molecular hairpin H1 concentrations were all 1 nmol·L -1 , the correlation coefficients are all greater than 0.99.
[0021] 3. The fluorescence on-sensor of the present invention has outstanding specificity for BRCA2 detection, especially for single-base mutations, and the lower the concentration of the molecular hairpin H1, the stronger its ability to recognize single-base mutations. The preparation and detection process of this method is simple and has outstanding specificity. It can not only be used for early screening of high-risk groups for breast cancer, but also provide a new method for early prediction and evaluation of breast cancer. It can also be expanded to other types of gene detection, providing a new method with simple preparation and convenient operation for the promotion and application of gene sensors. BRIEF DESCRIPTION OF THE DRAWINGS
[0022] In order to more clearly illustrate the embodiments of the present invention or the technical solutions in the prior art, the drawings required for use in the embodiments or the description of the prior art will be briefly introduced below. Obviously, the drawings described below are only some embodiments of the present invention. For ordinary technicians in this field, other drawings can be obtained based on these drawings without paying creative work.
[0023] Figure 1 This is a schematic diagram of the principle of the fluorescent on-sensor of the present invention for detecting BRCA2.
[0024] Figure 2 The diagram is an analysis of the optimization conditions for detecting BRCA2 using the fluorescence on sensor of the present invention, wherein (A) the optimization of the stabilization time after adding the target gene BRCA2; (B) the fluorescence change before and after adding BRCA2 to the fluorescence on sensor of two concentrations of H1 at different pH values; (C) the fluorescence value before and after adding BRCA2 to the fluorescence on sensor at different temperatures; (D) the fluorescence difference before and after adding BRCA2 to the fluorescence on sensor at different temperatures.
[0025] Figure 3 The fluorescence spectra of the fluorescence on-sensor with different concentrations of H1 after adding different concentrations of target gene and the relationship between the target gene concentration and the output fluorescence intensity of the fluorescence on-sensor, where the (AB)H1 concentration is 150 nmol·L -1 ; (CD)H1 concentration is 300 nmol·L -1 ; (EF)H1 concentration is 600 nmol·L-1 (The fluorescence intensity of the fluorescence on sensor output in A-F is taken when λ=581nm).
[0026] Figure 4 Specificity analysis of the fluorescence turn-on sensor at different concentrations of H1. DETAILED DESCRIPTION
[0027] The following will be combined with the drawings in the embodiments of the present invention to clearly and completely describe the technical solutions in the embodiments of the present invention. Obviously, the described embodiments are only part of the embodiments of the present invention, not all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention.
[0028] Unless otherwise specified, the experimental methods used in the embodiments of the present invention are conventional methods.
[0029] Unless otherwise specified, the materials, reagents, etc. used in the embodiments of the present invention can be obtained from commercial sources.
[0030] Among them, oligonucleotides were from Shanghai Shenggong Bioengineering Technology Co., Ltd.; hydrochloric acid (HCl), sodium hydroxide (NaOH), and sodium chloride (NaCl) were purchased from Zhengzhou Xinmaijie; sodium dihydrogen phosphate (NaH2PO4) was purchased from Shanghai Titan Technology Co., Ltd.; all the above reagents were analytically pure, and the solution was prepared with ultrapure water (≥18.2MΩ). The BRCA2 sequence was from (GenBank no. NM_000059).
[0031] In the embodiment of the present invention, the sequence of the molecular hairpin H1 is shown by SEQ ID No.1, the sequence of BRCA2 is shown by SEQ ID No.2, the sequence of MT1 is shown by SEQ ID No.3, the sequence of MT2 is shown by SEQ ID No.4, the sequence of MT3 is shown by SEQ ID No.5, and the sequence of NCT is shown by SEQ ID No.6. Example
[0032] 1. Oligonucleotide activation and detection of target gene BRCA2
[0033] Place H1 in a centrifuge at 7000 r / min -1 Centrifuge for 1 min, take out and add SPSC buffer (50 mmol·L -1 NaH2PO4; 1 mol·L -1 NaCl; pH = 8.0), keep it in dark place for 2 h, and then store it in a 4 ℃ refrigerator in dark place.
[0034] 10μ L, 20 μ L, 40 μ L H1(9.0 μ mol·L -1 ) and 20 μ Different concentrations (1, 5, 15, 30, 50, 75, 100, 150, 200, 300, 350, 400, 500, 600, 700, 800, 900 nmol·L -1 ) and BRCA2, add SPSC buffer (pH = 8.0) to a total volume of 600 μ L, and reacted in an incubator at 25 °C for 3.5 h. μ After the L reaction, the sample was placed in a quartz cuvette, and the excitation wavelength of the fluorescence spectrophotometer was set to 561 nm, the emission wavelength detection range was 565-650 nm, the excitation slit was 5 nm, and the emission slit was 5 nm. The fluorescence intensity of samples with different concentrations of BRCA2 was measured, and the relationship between different concentrations of BRCA2 and the fluorescence intensity was calculated.
[0035] 2. Detection principle
[0036] like Figure 1 As shown, hairpin H1 consists of three parts: a loop, a stem, and a sticky end. The loop consists of five guanine bases, the stem consists of ten complementary base pairs, and the junction between the loop and the stem is labeled with a fluorescent group, tetramethylrhodamine (TAMRA). Under the excitation of light, the electrons of the fluorescent group transition from the ground state to the excited state. When the electrons return to the ground state, energy is released in the form of light, generating fluorescence. However, in the single-stranded DNA composed of five G bases in the loop, the electrons from the guanine bases occupy the highest occupied orbital of the excited state of the fluorescent group, causing the electrons of the fluorescent group to be unable to return to the ground state, resulting in fluorescence quenching. The sticky end connected to the 5´ end protrudes for 5 bases. When the target gene is not introduced, H1 in the solution exists stably in a hairpin structure. When the target gene is added, BRCA2 starts to bind from the tail of the sticky end of H1, forming a competitive relationship with the stem connected to the 3´ end of H1, causing the hairpin stem to unwind. The target gene completely complementarily binds to the stem of H1 and its sticky end, causing the loop and stem to exist in a single-stranded form. This conformational change causes the TAMRA fluorescence to increase.
[0037] The fluorescence signal intensity before and after adding the target gene BRCA2 was measured using a fluorescence spectrophotometer. Figure 1 As shown in the fluorescence spectrum, when there is no target gene BRCA2 in the system, only 300 nmol·L -1The hairpin H1 is stable in the solution. Since the five G bases connected to the TAMRA ring transfer electrons to the fluorescent group through chemical bonds, the fluorescence of TAMRA itself is partially quenched, making the initial fluorescence intensity of the fluorescence on sensor low. When 15 nmol·L -1 When BRCA2 was added, hairpin H1 was opened and the fluorescence signal increased at a wavelength of 581 nm. When BRCA2 was added to 75 nmol·L -1 When the fluorescence value of TAMRA is restored to 1.5 times of the initial fluorescence, the concentration of BRCA2 added can be inferred based on the increase in the fluorescence signal.
[0038] 3. Condition optimization
[0039] In order to obtain better detection performance, the reaction time, temperature and pH of the fluorescence on-sensor were optimized as follows:
[0040] (1) Reaction time optimization: After adding the target gene BRCA2, the fluorescence value of the solution will gradually change over time. The fluorescence intensity is measured immediately after adding the target gene BRCA2 to explore its stability time. Figure 2 (A) It can be seen that the fluorescence intensity of the solution increased significantly when the reaction time was 0-50 minutes; the fluorescence intensity value increased slightly in the range of 50-200 minutes; after 200 minutes, the fluorescence value tended to be stable. Considering the experimental effect comprehensively, the optimal time for this reaction was selected to be 50 minutes.
[0041] (2) Reaction temperature optimization: Since the molecular hairpin H1 and the fluorescent group TAMRA both fluctuate greatly with temperature, the reaction temperature of this experiment was optimized. The detection range of 0-60 ℃ was selected, and the fluorescence intensity before and after adding the target gene BRCA2 was measured at every 5 ℃ interval. Figure 2 (C) It can be seen that before adding the target gene BRCA2, the fluorescence intensity gradually decreased in the range of 0-35 ℃, and at 35-60 ℃, the fluorescence intensity gradually increased with the increase of temperature. After adding the target gene BRCA2, the fluorescence intensity gradually decreased in the range of 0-60 ℃. Definition ΔF = F - F 0 ( F is the fluorescence signal intensity after adding the analyte, F 0 is the fluorescence signal intensity when no analyte is added), Figure 2 (D) It can be seen that the difference in fluorescence signal intensity before and after the addition of the target gene BRCA2 also showed a downward trend with the increase in temperature. In order to simplify the experimental conditions, 25 ℃ room temperature was finally selected as the reaction temperature.
[0042] (3) pH optimization: Strong acid or strong base environment can easily cause the hydrogen bond of the stem of molecular hairpin H1 to break, so the molecular hairpin H1 was selected to have a pH of 150 nmol·L -1 and 300 nmol·L -1 The two concentrations optimized the pH of the solution reaction environment. At both concentrations, H1 prepared two groups of samples with and without target DNA, and each group of samples was titrated to nine pH values of 3, 5, 6.5, 7, 7.5, 8, 8.5, 9, and 11. Figure 2 (B) It can be seen that at pH values of 3 and 11, the hairpin structure may have been destroyed, so the quenching effect of the G base on TAMRA was inhibited, and the fluorescence value of the solution increased significantly. For the difference in fluorescence signal intensity before and after adding the target gene BRCA2, both H1 concentrations showed a weak trend of first increasing and then decreasing, which was Figure 2 (B) It can be seen that when the pH value is in the range of 7-8, the fluorescence signal intensity difference reaches the strongest, so pH=8 is selected as the reaction condition.
[0043] Implementation effect example
[0044] 1. BRCA2 detection
[0045] Using the detection method of the target gene BRCA2 in the example and the optimized experimental conditions, the detection effect of the fluorescence on-sensor of the molecular hairpin H1 of the present invention on the target gene BRCA2 of different concentrations was analyzed. The results are as follows: Figure 3 . Use SPSC buffer (pH=8) to prepare 150, 300, and 600 nmol·L -1 Three concentrations of H1 were used as sensor working solutions, with the prepared concentrations being 1, 5, 15, 30, 50, 75, 100, 150, 200, 300, 350, 400, 500, 600, 700, 800, and 900 nmol·L -1 BRCA2 of different concentrations was used as the test sample. The test samples of BRCA2 with different concentrations were mixed with 150 nmol·L -1 After mixing with H1, the results were detected by fluorescence spectrophotometer. Figure 3 (AB) As shown in the figure, as the concentration of BRCA2 increases, the fluorescence intensity of the fluorescence on sensor gradually increases. The detection range of BRCA2 is 1-100 nmol·L -1 , 1-50 nmol·L -1 There is a good linear relationship between the interval input and output, and the linear regression equation is ΔF =10.362 c +83.629. Similarly, adjust the concentration of H1 to 300 nmol·L -1 、600 nmol·L-1 , the sensor detection results are as follows Figure 3 (CF), and its detection range is 1-150 nmol·L -1 , 1-300 nmol·L -1 The linear detection range is 1-100 nmol·L -1 , 1-200 nmol·L -1 The regression equations are ΔF =10.511 c +104.194, ΔF =12.408 c +162.828. At three H1 concentrations, the detection limit of the sensor can reach 1 nmol·L -1 , the correlation coefficients are all greater than 0.99. By adjusting the concentration of the molecular hairpin H1 in the sensor, the BRCA2 detection range can be adjusted. This method can also be extended to other target gene detection.
[0046] 2. Specificity
[0047] To verify the specificity of the fluorescence on-sensor of the present invention, the target gene BRCA2 (T), DNA with single base (MT1), double base (MT2), triple base (MT3) mismatch with the target gene BRCA2, and completely non-complementary DNA (NCT) of the same volume and concentration were added to the molecular hairpin H1 of the same volume and concentration, and the volume was fixed to 600 μL. μ After L, the fluorescence signal was measured. The results were as follows Figure 4 As shown, η = ΔF M / ΔF T Quantify specific results, (where ΔF M It represents the difference between the output signal intensity of the sensor and the background fluorescence signal intensity when the target gene is mismatched. ΔF T It represents the difference between the output signal intensity of the sensor and the background fluorescence signal intensity when the same concentration of target gene is added), H1=150 nmol·L -1 When MT1, MT2, MT3, NCT mismatch base sequences η 13.9%, 4.6%, 6.2%, 1.5% respectively; H1: 300 nmol·L -1 21.7%, 13.0%, 9.2%, 8.8%; H1=600 nmol·L -1When the concentration of H1 is lower, the single base mismatch specificity of the fluorescence on sensor of the present invention is stronger when detecting the target gene BRCA2. The detection effect of the method for detecting BRCA gene of the present invention is compared with the detection effect of various BRCA gene detection methods at present, and the results are shown in Table 1.
[0048] Table 1 Comparison of different methods for detecting BRCA genes
[0049]
[0050] Among them, the source of method 1 is [Ribovski L, Zucolotto V, Janegitz B C. Microchemical Journal, 2017, 133: 37.], the source of method 2 is [Ehzari H, Safari M, Shahlaei M.Microchemical Journal, 2018, 143: 118.], the source of method 3 is [Rasheed PA, Sandhyarani N. Colloids and Surfaces B: Biointerfaces, 2014, 117: 7.], the source of method 4 is [AbduláRasheed P. Analyst, 2015, 140(8): 2713.], the source of method 5 is [Muti M, Muti M.Electroanalysis, 2017, 29(10): 2208.], and the source of method 6 is [Yang H, Gao Y, Wang S, et al. Biosensors and Bioelectronics, 2016, 80: 450.], method 7 is from [Liu J, Wang T, Xiao B, et al. Analytical Methods, 2021, 13(5): 712.], method 8 is from [Zhong D, Yang K, Wang Y, et al. Talanta, 2017, 175: 217.], method 9 is from [Borghei YS, Hosseini M, Ganjali MR, et al. Materials Science and Engineering: C, 2019,97: 406.], method 10 is from [Ai X, Ma Q, Su X. Analytical biochemistry, 2013, 438(1): 22.], method 11 is from [Zhang H, Wang L, Jiang W. Talanta, 2011, 85(1): 725.], and method 12 is the detection method of the present invention.
[0051] Compared with Table 1, it can be seen that the sensor prepared by this method has a strong ability to distinguish single-base mismatch sequences, and can realize disease prediction and evaluation at an early stage.
[0052] 3. Conclusion
[0053] The present invention realizes accurate detection of BRCA2 in one step by designing a special DNA hairpin (molecular hairpin H1). When the temperature is 25°C, the time is 50 minutes, and the pH is 8, the concentration of the molecular hairpin H1 is changed, and the linear detection range of the fluorescence on-sensor for BRCA2 can be 1-200 nmol·L -1 The detection limit was 1 nmol·L -1 The sensor has outstanding specificity, especially for single-base mutations. The construction of this sensor provides a new method for rapid DNA detection, and this method has outstanding specificity and is easy to operate, and is expected to be expanded to the detection of other oncogenes.
[0054] The above description is only a preferred embodiment of the present invention and is not intended to limit the present invention. Any modifications, equivalent substitutions, improvements, etc. made within the spirit and principle of the present invention should be included in the protection scope of the present invention.
Claims
1. A fluorescent on-sensor for detecting BRCA2, characterized in that: The fluorescence on sensor is obtained by centrifuging the molecular hairpin H1, dissolving it in SPSC buffer, activating it, and keeping it in the dark for 2 hours; The molecular hairpin H1 nucleotide sequence is shown in SEQ ID No. 1, and consists of three parts: a loop, a stem, and a sticky end. The loop is composed of 5 guanine bases, the stem is composed of 10 complementary base pairs, and the connection between the loop and the stem is labeled with a fluorescent group TAMRA; The concentration of the molecular hairpin H1 is 150-600 nmol·L -1 .
2. The fluorescence on sensor according to claim 1, characterized in that: The formula of the SPSC buffer is NaH2PO450 mmol·L -1 and NaCl 1 mol·L -1 , adjust pH=8.
0.
3. Use of the fluorescent on-sensor according to claim 1 or 2 in the preparation of a biological detection tool for detecting BRCA2.
4. The use according to claim 3, characterized in that: The steps of detecting BRCA2 by fluorescence on-sensor are as follows: add SPSC buffer of the test solution to the working solution of the fluorescence on-sensor, then use a fluorescence spectrophotometer to detect the change in fluorescence intensity, and substitute the fluorescence intensity change value ΔF And its corresponding BRCA2 standard solution concentration c The concentration of BRCA2 in the test solution was calculated using the standard curve equation.
5. The use according to claim 4, characterized in that: The working conditions of the fluorescence on-sensor are temperature 25°C, time 50 min, and pH = 8.
0.
6. The use according to claim 5, characterized in that: The concentration of the molecular hairpin H1 in the working solution of the fluorescence on-sensor is 150 nmol·L -1 The detection range is 1-100 nmol·L -1 The standard curve equation is ΔF =10.362 c +83.629; the concentration of molecular hairpin H1 is 300 nmol·L -1 The detection range is 1-150 nmol·L -1 The standard curve equation is ΔF =10.511 c +104.194; the concentration of molecular hairpin H1 is 600 nmol·L -1 The detection range is 1-300 nmol·L -1 The standard curve equation is ΔF =12.408 c +162.828.
